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signiﬁcant decrease of serum total lipids, triglycerides, total cholesterol, LDL-cholesterol and
vLDL-cholesterol levels. Whereas, HDL-cholesterol concentration was markedly increased by
180%. Aqueous extract showed a signiﬁcant ameliorative action on elevated atherogenic index, cre-
atine kinase and lactate dehydrogenase activities of hypercholesterolemic group. Furthermore,
serum activities of transaminases and alkaline phosphatase were also improved. High fat diet intake
caused a highly signiﬁcantly elevated serum urea, creatinine concentration. These effects were
reversed by oral administration of U. lactuca extract. Sulfates polysaccharides extract of U. lactuca
ameliorate hepatic enzymatic (catalase, glutathione peroxidase and superoxide dismutase), non-
enzymatic (reduced glutathione & total thiol) antioxidant defenses and thiobarbituric acid reactive4649477.
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In recent years, many marine resources have attracted attention
in the search for bioactive compounds to develop new drugs
and health foods (Huimin et al., 2005). In addition, marine
algae are now considered a rich source of antioxidants (Nagai
and Yukimoto, 2003). It is known that seaweeds contain
numerous bioactive substances that have been shown to lower
cholesterol, reduce blood pressure, promote healthy digestion;
and antioxidant activity (Raghavendran et al., 2005). Algal
polysaccharides have been demonstrated to play an important
role as free-radical scavengers in vitro and antioxidants for the
prevention of oxidative damage in living organisms (Zhang
et al., 2004). Polysaccharide extracted from Ulva pertusa is a
group of heteropolysaccharide, mainly composed of rhamnose,
xylose, glucose, glucuronic acid, iduronic acid, and sulfate, with
smaller amounts of mannoses, arabinose, and galactose (Hui-
min et al., 2005).
Cholesterol-enriched diet has been reported to adversely af-
fect the health of humans and animal species. The prevalence
of dyslipidemia resulting from excess energy intake and phys-
ical inactivity is increasing in Egypt. High level of blood cho-
lesterol is a contributory factor of atherosclerosis and many
lipid associated ailments like obesity, heart attacks and stroke
and kidney failure (Sathivel et al., 2008). It has been reported
that high levels of fat increase fat-mediated oxidative stress
and decrease antioxidative enzyme activity (Slim et al.,
1996). In contrast, there are various reports indicating the ben-
eﬁcial effects of antioxidant supplementation in preventing
dyslipidemia and cardiovascular disease (Minhajuddin et al.,
2005; Gorinstein et al., 2006). Thus, oxidative damage and
its consequences may result in many chronic health problems
that are attributed to high fat diet.
Many therapeutic agents are available for the management
of hypercholesterolemic patients and are employed to promote
successful treatment. A number of studies have demonstrated
that the use of lipid-lowering drugs can reduce the number
of cardiovascular events and mortality from coronary disease
(Aronow, 2008). Moreover, a diet restricted in foods high in
cholesterol and regular physical exercise should be proposed
in the treatment of these patients, contributing signiﬁcantly
to primary health care (De Lorgeril et al., 1999). However,
due to certain resistances to dietary restriction and ﬁnancial
limitations to use lipid-lowering drugs, many individuals have
turned to alternative treatments to control cholesterol levels.
Many of these alternative treatments have been used empiri-
cally, lacking scientiﬁc studies that would allow for more reli-
able conclusions (Dickel et al., 2007).
Thus, it is essential to develop and utilise effective and nat-
ural antioxidants so that they can protect the human body
from free radicals and retard the progress of many chronic dis-
eases. Published data indicates that plant polysaccharides in
general have antioxidant activities and explored as novel po-
tential antioxidants (Ng et al., 2004; Jiang et al., 2005; Wang
and Luo, 2007). The structure and mechanisms of the pharma-
ceutical effects of bioactive polysaccharides on diseases havebeen extensively studied, and more natural polysaccharides
with different curative effects have been tested and even ap-
plied in therapies. Thus, the present study was designed to
evaluate the possible beneﬁcial effect of the extracted sulfated
polysaccharide from Ulva lactuca on serum lipid parameters
and hepatic oxidative stress parameters in albino rats fed with
cholesterol-rich diet.
2. Materials and methods
2.1. Algal collection
U. lactuca Linnaeus was collected from Al-Quser province,
Red Sea coast, Egypt (at 26 070 N and 34 130 E) in December
2007. The algal material were washed with tap water many
times and further washed two times with distilled water to re-
move epiphytes, salts and sands. They were air dried in shade
and ground by a blender to give small size pieces (2 mm) then
stored in plastic bags at room temperature in a dry dark place
before use.
2.2. Polysaccharides extraction
Dry algal material (100 g) was autoclaved in 3 L of water at
100 C for 2 h, and the slurry separated and ﬁltered. The
ﬁltrate was dialyzed against tab water for 48 h, and then
concentrated to about 800 ml under reduced pressure and
95% ethanol (3 L) was added. The mixture was allowed to
stand for overnight at room temperature, and the precipitate
was collected and washed twice with absolute ethanol (Pengz-
han et al., 2003).
2.3. Infra red measurements
Fourier-transformed infrared spectra were recorded from the
polysaccharide powder extract (about 1 mg) in KBr (300 mg)
pellets on Shimadzu FT-IR 8201 PC spectrophotometer
(El-Sayed et al., 2005).
2.4. Polysaccharides hydrolysis and composition analysis
The isolated crude polysaccharides (5 mg) hydrolyzed with
0.5 M H2SO4 at 105 C for 20 h then neutralized by using
BaCO3 and ﬁnally centrifuged. The supernatant was concen-
trated and examined by paper chromatography (PC, descend-
ing) using B/A/W (4:1:5 v/v, upper layer) as solvent system.
The hydrolysate were also examined by thin layer chromatog-
raphy (TLC) using the system CHCl3/MeOH/H2O (15:6:2 v/v)
(Chen et al., 1997). The spots were visualized by spraying with
aniline phthalate reagent. The hydrolysates (20 ll) were also
analysed by HPLC HP1050 model equipped with UV detector
(set at 192 nm), Hewlett Packard (HPLC laboratory, Agricul-
ture Research center, Cairo) using the following conditions:
Column: APS Hypersil column (4.6 · 200mm i.d.), mobile
phase: acetonitrile/water (75:25) v/v., ﬂow rate: 2 ml/min.
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tion time data with those of the reference standards, which
were also run under identical analytical conditions.
2.5. Animals
White male albino rats Rattus norvegicus (Research Institute of
Ophthalmology, Giza, Egypt) weighing between 120 and 140 g
were used for the evaluation of antioxidant and antihypercho-
lesterolemic actions of sulfated polysaccharides from U. lactu-
ca. These animals were housed in stainless steel cages (six in
each cage, 36 rat for total represented 6 groups) under ambient
temperature of 27 ± 2 C with 12 h light/dark schedule. They
were fed with the standard commercial diet (ATMID Com-
pany, Egypt) and provided with tap water for 7 days to be
acclimatized with the hold. Then they were weighed and serum
triglycerides, total and HDL-cholesterol concentrations were
measured.
2.6. Experimental design
Based on data, the normal rats were divided into six groups of
six rats each as follows:
Group I served as negative control (given distilled water).
Group II were administered normal rats given U. lactuca ex-
tract at a dosage of 175 mg/kg body weight dissolved in dis-
tilled water, this dose was calculated from the therapeutic
dose (250 mg/kg body weight) for mice (Pengzhan et al.,
2003). Group III were given the drug Atorvastatine (pur-
chased from Pﬁzer-Egypt Company) at a dosage of 10 mg/kg
body weight dissolved in distilled water, this dose was calcu-
lated from the therapeutic dose (10 mg/day) for human beings
(Koter et al., 2002) by using the conversion table of Paget and
Barnes (1964). All treatments were given orally and daily for
4 weeks. Normal groups were continued to be provided with
the common commercial rat chow.
Hypercholesterolemia was induced to the remaining rat
groups by addition of cholesterol powder, bile salt and animal
lard to the standard diet in percentage of 1%, 0.25% and 4%,
respectively (Pengzhan et al., 2003) for about 21 days. Blood
samples were withdrawn from lateral tail vein, centrifuged
and serum lipid proﬁles were measured. The considered hyper-
cholesterolemic rats were divided into three groups; hypercho-
lesterolemic group (positive control, group IV) that continued
fed with high fat diet throughout the study period (4 weeks).
Group V was treated with U. lactuca extract (175 mg/kg body
weight) and the last one (group VI) was given atorvastatine
(10 mg/kg body weight) orally and daily by gastric intubation
for 4 weeks.
Body weight gain was calculated from the difference
between the initial weight at the beginning and the ﬁnal weight
at the end of the experiment. To reduce the error originating
from feeding, all animals were fasted (water was not restricted)
for 10 h before measurement.
By the end of the 4th week, animals of different groups were
sacriﬁced under diethyl ether anesthesia. Blood samples were
taken, left to coagulate at room temperature and centrifuged
at 3000 rpm for 30 min. The clear, non hemolysed, supernatant
sera were quickly removed and kept at 20 C till used for bio-
chemical investigations.
Liver was rapidly excised from each rat; 0.5 g from each
liver was homogenized in 5 ml saline solution using Teﬂonhomogenizer. The clear homogenate was used for estimation
of non-enzymatic (GSH & T. thiol) and enzymatic (CAT,
SOD and GSH-Px) antioxidant defense system and lipid perox-
idation products (TBARS).2.7. Biochemical examination
Serum total lipids concentration was determined according to
the method of Frings et al. (1972) using kits purchased from
Diamond Diagnostic (Egypt). Serum triglycerides (TGs) con-
centration was determined according to the method of Fossati
and Prencipe (1982) using reagent kit purchased from Reacti-
vos Spinreact Company (Spain). Serum cholesterol concentra-
tion was estimated according to the method of Deeg and
Ziegenohrm (1983) and serum HDL-cholesterol concentration
was measured according to the method of Burstein et al. (1970)
using reagent kit purchased from Spinreact Company (Spain).
Serum LDL-cholesterol concentration was determined accord-
ing to Friedewald et al. (1972) formula:
LDL Cholesterol ¼ Total cholesterol Triglycerides
5
 ðHDL CholesterolÞ
Serum very low density lipoprotein (vLDL) was determined
according to Norbert (1995) formula:
vLDL Cholesterol conc ¼ Triglycerides=5:
The Atherogenic index (AI) was calculated by the following
formula: (Harnaﬁ et al., 2008)
AI ¼ ðTotal cholesterolHDL CholesterolÞ=HDL
 Cholesterol:
Both alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) activities were assayed according to the
method of Reitman and Frankel (1957) using reagent kits pur-
chased from Randox Company (UK). Alkaline phosphatase
(ALP) activity was determined according to the method de-
scribed by Belﬁeld and Goldberg (1971) using reagent kits ob-
tained from Bio-Merieux Chemical Company (France). Urea
concentration was estimated according to the method of Pat-
ton and Crouch (1977) and serum creatinine concentration
was measured according to the method of Henry (1974) using
reagent kit purchased from Diagnostics Company (Egypt).
Serum creatine kinase (CK-NAC) activity was determined
according to the method of Young (1975) and lactate dehydro-
genase (LDH) activity in serum was determined according to
the method of Buhl and Jackson (1978) using reagent kit pur-
chased from Stanbio Laboratories (Texas, USA).
The levels of hepatic reduced glutathione (GSH) and total
thiol (T. thiol) were determined by the methods of Beutler
et al. (1963) and Koster et al. (1986), respectively. The activity
of hepatic superoxide dismutase (SOD) was measured accord-
ing to the method of Marklund and Marklund (1974). Liver
catalase (CAT) was determined according to the technique of
Cohen et al. (1970) and the results were expressed in terms
of the ﬁrst-order reaction rate constant (K). Glutathione per-
oxidase (GSH-Px) was estimated according to the methods of
Pinto and Bartley (1969). Thiobarbituric acid reactive sub-
stances (TBARS) indicative of lipid peroxidation was deter-
mined by the thiobarbituric acid reaction in the liver tissue
according to the method of Preuss et al. (1998).
Figure 1 The IR spectrum of Ulva lactuca polysaccharide
extract.
Table 1 Monosugar content of Ulva lactuca polysaccharide
extract.
Monosugar type Retention time
Rhamnose 1.4
Galactose 2.2
Glucose 2.4
Arabinose 3.6
Xylose 3.8
Mannose 4.3
Glucuronic acid 4.8
Galacturonic acid 5.5
336 S. Hassan et al.2.8. Chemicals
All chemicals and reagents used in the present study were of
the highest purity available, and were purchased from Sigma
(St Louis, MO, USA) and Merck (Darmstadt, Germany)
Companies.
3. Statistical analysis
The data were analysed using one-way analysis of variance
(ANOVA, PC-STAT program, 1995) followed by least signif-
icant difference (LSD) analysis to compare various groups
with each other. Results were expressed as mean ± standard
deviation and values of P> 0.05 were considered statistically,
non-signiﬁcantly different, while those of P 6 0.05 and P 6
0.01 were statistically signiﬁcantly and highly signiﬁcantly
different, respectively.
4. Results and discussion
The current study was designed to examine the cholesterol
lowering, antioxidative activity and possible mechanism(s) of
green alga U. lactuca.
4.1. Infra red measurements
IR (cm1) spectrum of U. lactuca polysaccharide extract re-
vealed presence of absorption bands at 1633.3, 1263.2 and
1051.3 cm1 that indicated the presence of C‚O of uronic
acids, the stretching vibration of S‚O of sulfate and the vibra-
tion of C–O–C bridge of glucosides, respectively. The signal at
789.8 cm1 might demonstrate to the binding vibration of C–
O–S of sulfate in equatorial position. The previous gained data
dealt with the presence of sulfate functional groups in our ex-
tract (Pengzhan et al., 2003) (Fig. 1).
4.2. Polysaccharides composition
The monosugars content of U. lactuca obtained after hydroly-
sis and subjected to HPLC analysis, proved the presence of
rhamnose, galactose, glucose, arabinose, xylose, mannose glu-
curonic acid and galacturonic acid at various retention times
(Table 1).
4.3. Biochemical examination
4.3.1. Serum lipid proﬁle
The present results elucidated high signiﬁcant increase in serum
total lipids, total cholesterol, triglyceride, LDL-cholesterol and
vLDL-cholesterol concentrations in hypercholesterolemic
control rats and highly signiﬁcant decreased HDL-cholesterol
levels as compared to normal rats (Table 2). These results run
in parallel with those of other investigators (Jang et al.,
2008). The hypercholesterolemic effect may be ascribed to the
increased dietary cholesterol intake (Zulet et al., 1999) and
subsequently increased rate of intestinal cholesterol absorption
(Mathe´, 1995). Lard fat is rich in saturated fatty acids, known
to increase serum and LDL-cholesterol, and in monounsatu-
rated fatty acids, which can increase serum triacylglycerols
(Higashi et al., 1997; Lichtenstein et al., 1998). In addition, in-
creased serum concentration of triglycerides may be attributedto decreased clearance of triglycerides secondary to decreased
activity of lipoprotein lipase (LPL) (Nofer et al., 2002). The
high level of LDL-cholesterol found in hypercholesterolemic
rats may be attributed to a down regulation in LDL receptors
by cholesterol and saturated fatty acids included in the diet
(Mustad et al., 1997). Reduction in HDL following cholesterol
feeding may be due to contributed acceleration of apoA-I clear-
ance from the plasma based on cholesterol-enriched diets (Sor-
ci-Thomas et al., 1989).
Treatment of hypercholesterolemic rats with U. lactuca
polysaccharide extract induced marked signiﬁcant decrease
of serum total lipids (61%), total cholesterol (49.6%), tri-
glycerides (66%) and LDL-cholesterol (93%) concentra-
tions as compared to the hypercholesterolemic rats. Rats
treated with algal extract showed improved high signiﬁcant le-
vel of HDL-cholesterol (+180%, as compared to hypercholes-
terolemic rats), which may be due to the ability of the extract
to hasten the decomposition of free radical species generated
during cholesterol administration (Raghavendran et al.,
2005; Godard et al., 2009). Where, HDL-C is a free radical
scavenger and prevents peroxidation of beta lipoproteins
(Chander and Kapoor, 1990). The polysaccharides from U.
Table 3 Effects of U. lactuca extract and atorvastatine supplementation on Atherogenic index, creatine kinase and lactate
dehydrogenase activities of normal and hypercholesterolemic rats.
Groups Parameters
AI Creatine kinase (U/L) LDH (lKat/L)
Control (Gr. I) 0.65 ± 0.06c 19 ± 0.52d 104.37 ± 1.03d,e
U. lactuca (Gr. II) 1.19 ± 0.32c 13.31 ± 0.27f 114.75 ± 2.05a,b
Atorvastatine (Gr. III) 2.17 ± 0.39b 16.83 ± 0.86e 105.60 ± 5.04c,d
Hypercholesterolemic (Gr. IV) 5.91 ± 1.86a 61.64 ± 3.63a 116.46 ± 6.45a
U. lactuca (Gr. V) 0.44 ± 0.17c 24.90 ± 1.43c 110.78 ± 7.39b,c
Atorvastatine (Gr. VI) 0.45 ± 0.44c 33.18 ± 1.46b 99.76 ± 2.51e
LSD
5% 0.93 2.064 5.56
1% 1.26 2.78 7.48
Gr, Group; AI, Atherogenic index; LDH, Lactate dehydrogenase; LSD, least signiﬁcance difference; Data are expressed as mean ± SD (n= 6).
Means which are not signiﬁcantly different have the same symbol; signiﬁcance level at P 6 0.05.
Table 4 Effects of U. lactuca extract and atorvastatine supplementation on body weight change, liver (ALT, AST and ALP activities),
kidney (urea, creatinine and urea/creatinine ratio) functions tests of normal and hypercholesterolemic rats.
Groups Parameters
Body wt. changes (%) ALT (U/L) AST (U/L) ALP (U/L) Urea (mg/dl) Creatinine (mg/dl) Urea/Creatinine ratio
Control (Gr. I) 10.6 ± 1.9c 36.4 ± 4.8c 19.4 ± 2.3d 219.6 ± 5.0b 25.2 ± 1.0d 0.87 ± 0.12d 29.2 ± 4.3a,b
U. lactuca (Gr. II) 13.3 ± 2.6b,c 38.4 ± 3.4b,c 19.5 ± 0.8d 148.9 ± 3.1c 25.1 ± 2.9d 1.08 ± 0.12c 23.4 ± 2.8c
Atorvastatine (Gr. III) 14.3 ± 3.5b 30.4 ± 3.6d 20.5 ± 2.1d 104.5 ± 7.9d 30.1 ± 2.9c 1.10 ± 0.07c 27.4 ± 2.5a,b
Hypercholesterolemic
(Gr. IV)
21.3 ± 2.7a 90.3 ± 5.4a 73.8 ± 3.0a 469.7 ± 19.1a 54.3 ± 3.2a 1.78 ± 0.15a 30.8 ± 4.3a
U. lactuca (Gr. V) 14.9 ± 3.4b 42.1 ± 3.2b 37.6 ± 1.5c 211.2 ± 2.0b 33.3 ± 1.3b 1.26 ± 0.10b 26.6 ± 3.0b,c
Atorvastatine (Gr. VI) 16.4 ± 3.4b 36.1 ± 1.9c 53.4 ± 2.7b 221.5 ± 7.0b 33.6 ± 1.5b 1.25 ± 0.10b 27.1 ± 2.8a,b,c
LSD
5% 3.5 4.6 2.6 11.0 2.7 0.13 4.0
1% 4.7 6.2 3.5 14.7 3.7 0.18 5.4
Gr, Group; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; ALP, Alkaline phosphatase; LSD, least signiﬁcance difference;
Data are expressed as mean ± SD (n= 6). Means which are not signiﬁcantly different have the same symbol; signiﬁcance level at P 6 0.05.
Table 2 Effects of U. lactuca extract and atorvastatine supplementation on body serum lipid proﬁle of normal and hypercholes-
terolemic rats.
Groups Parameters
Total lipids (mg/dl) TG (mg/dl) TC (mg/dl) LDL-C (mg/dl) VLDL-C (mg/dl) HDL-C (mg/dl)
Control (Gr. I) 114.0 ± 6.1d 44.0 ± 3.3c 45.2 ± 3.5b 9.0 ± 1.2c 8.8 ± 0.7c 27.5 ± 2.4a
U. lactuca (Gr. II) 147.2 ± 5.9c 56.0 ± 2.4b 28.6 ± 1.8d 4.3 ± 0.7d 11.2 ± 0.5b 13.1 ± 2.5bc
Atorvastatine (Gr. III) 175.6 ± 4.0b 56.9 ± 12.4b 44.1 ± 2.8b 18.5 ± 2.9b 11.4 ± 2.5b 14.3 ± 1.8b
Hypercholesterolemic (Gr. IV) 228.9 ± 5.2a 122.0 ± 2.5a 80.9 ± 3.5a 45.3 ± 3.4a 24.4 ± 0.5a 11.2 ± 0.9c
U. lactuca (Gr. V) 88.8 ± 4.3e 41.2 ± 2.0 c 40.3 ± 2.2c 2.6 ± 1.0d 8.2 ± 0.4c 29.4 ± 1.5a
Atorvastatine (Gr. VI) 153.5 ± 7.4c 46.2 ± 2.7c 39.8 ± 2.2c 3.8 ± 1.5d 9.2 ± 0.5c 27.9 ± 1.7a
LSD
5% 6.6 6.6 3.2 2.6 1.3 2.2
1% 8.9 8.9 4.3 3.5 1.8 2.9
Gr, Group; TG, Triglycerides; TC, Total cholesterol; LDL-C, low density lipoprotein cholesterol; VLDL-C, very low density lipoprotein
cholesterol; HDL-C, high-density lipoprotein cholesterol; LSD, least signiﬁcance difference; Data are expressed as mean ± SD (n= 6). Means
which are not signiﬁcantly different have the same symbol; signiﬁcance level at P 6 0.05.
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mechanism by which extract regulate TC, TG and LDL-C is
unknown.
4.3.2. Atherogenic index, creatine kinase and lactate
dehydrogenase
Table 3 revealed that, the hypercholesterolemic control rats
exhibited a profound increase in atherogenic index (AI) as com-pared to normal ones. This atherogenicity thought to be due to
the atherogenic lipoprotein subclasses commonly associated
with hyperlipidemia (Hodis, 1999). The result indicated that,
treatment using U. lactuca extract and atorvastatin exhibited
signiﬁcant decrease of AI (94% and 92.4%, respectively,
as compared to hypercholesterolemic control rats) that might
be ascribed to their plasma lipid-lowering activity. Cytosolic
enzymes, lactate dehydrogenase (LDH) and creatine kinase,
Table 5 Effects of U. lactuca extract and atorvastatine supplementation on hepatic oxidative stress parameters of normal and
hypercholesterolemic rats.
Groups Parameters CAT
(K·10-2)
GSH-Px SOD (U/g) GSH
(nmol/100mg tissue)
T. Thiol
(nmol/100mg tissue)
TBARS
(nmol/100mg tissue)
Control (Gr. I) 53.7 ± 4.2a 1.26 ± 0.22a 5.07 ± 0.30b 0.64 ± 0.03a 12.05 ± 2.25a 0.53 ± 0.03d
U. lactuca (Gr. II) 43.4 ± 2.2b 0.74 ± 0.02bc 3.43 ± 0.36d 0.48 ± 0.01b 7.05 ± 0.22c 0.56 ± 0.03d
Atorvastatine
(Gr. III)
37.1 ± 2.9c 0.63 ± 0.02c 3.10 ± 0.29d 0.49 ± 0.01cd 7.53 ± 0.25c 0.74 ± 0.01a
Hypercholesterolemic
(Gr. IV)
19.2 ± 2.0d 0.51 ± 0.05d 2.72 ± 0.33e 0.49 ± 0.01bcd 4.93 ± 0.53d 0.75 ± 0.04a
U. lactuca (Gr. V) 34.0 ± 2.0c 0.63 ± 0.14c 5.72 ± 0.28a 0.50 ± 0.01bc 9.80 ± 0.06b 0.59 ± 0.04c
Atorvastatine (Gr. VI) 45.0 ± 2.4b 0.76 ± 0.02b 4.08 ± 0.25c 0.51 ± 0.01b 7.12 ± 0.13c 0.63 ± 0.01b
LSD 5% 3.21 0.11 0.36 0.02 1.13 0.03
1% 4.33 0.15 0.49 0.02 1.52 0.05
Gr, Group; CAT, Liver catalase; K, ﬁrst-order reaction rate constant; GSH-Px, Glutathione peroxidase; SOD, superoxide dismutase; GSH,
hepatic reduced glutathione; T. Thiol, total thiol; TBARS, Thiobarbituric acid reactive substances; LSD, least signiﬁcance difference; Data are
expressed as mean ± SD (n= 6). Means which are not signiﬁcantly different have the same symbol; signiﬁcance level at P 6 0.05.
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They leak out from the damaged tissues to the blood stream
when the cell membrane becomes permeable or rupture (Gu¨r-
gu¨n et al., 2008). Therefore, elevated enzymes activity in serum
of hypercholesterolemic control rats reﬂects the alterations in
plasma membrane integrity and/or permeability. The declined
enzymes activity secondary to drug and the alga treatments
might be ascribed to their ability to maintain membrane integ-
rity thereby restricting the leakage of these enzymes (Rajadurai
and Stanely Mainzen Prince, 2006; Zhou et al., 2008).
4.3.3. Liver enzymes activity and kidney functions
In this study, serum alanine aminotransferase (ALT) and
aspartate aminotransferase (AST) and alkaline phosphatase
(ALP) activities were signiﬁcantly high in high-cholesterol
fed diet than in normal rats, these results agreed with those
of Sudhahar et al. (2007). High fat diet intake caused a highly
signiﬁcantly elevated serum urea and creatinine concentrations
of hypercholesterolemic control rats as compared to normal
rats (Table 4). Enhanced protein catabolism and accelerated
amino acid deamination for gluconeogenesis is possible, an
acceptable postulate to interpret the elevated levels of urea,
where elevated creatinine concentration is associated with
abnormal renal function (Bishop et al., 2005). In this way, cho-
lesterol-enriched diet increased excretion of indicative parame-
ters of renal dysfunction such as urea, creatinine. These data
are in agreement with previous studies which showed that
hypercholesterolemia induces glomerular injury (Tolins et al.,
1992; Montilla et al., 2006).
4.3.4. Antioxidant enzymes activity
Complexes of free radical scavenging enzymes, such as liver cat-
alase (CAT), glutathione peroxidase (GSH-Px) and superoxide
dismutase (SOD) had evolved to prevent excessive oxidant
stress (Table 5). Supplementation with algal polysaccharides
was found to increase the activity of the antioxidant enzymes
by 110%, 77% and 23%, respectively, as compared with the
hypercholesterolemic control rats. A reduction of these en-
zymes activity is associated with the accumulation of highly
reactive free radicals, leading to deleterious effects such as loss
of integrity and function of cell membranes (Sheela and
Augusti, 1995). When they are present in high concentrations,free radicals are able to interact with the enzymes and inactivate
them (Pigeolet et al., 1990). Zhang et al. (2003) have reported
an increase in antioxidant status in ageing mice on supplemen-
tation with polysaccharide fraction from the alga Porphyra
haitanesis.
Apart from enzymatic antioxidants, non-enzymatic antioxi-
dants, hepatic reduced glutathione (GSH) and total thiol
(T. thiol) play a vital role in protecting cells from oxidative
damage (Table 5). GSH and T. thiol in hypercholesterolemic
rats decreased signiﬁcantly (23% and 59%, respectively)
when compared with the normal ones. These reductions may
be due to the increased utilization of these anti-oxidants for
quenching enormous free radicals producedduringhypercholes-
terolemic condition (Table 5). Qi et al. (2006) shown the strong
anti-oxidant activity (in vitro) of high sulfate content in polysac-
charide extracted fromU. pertusa. Thus, the increasedGSHand
T. thiol content in both hypercholesterolemic groups may be
attributed to the ability of atorvastatin and U. lactuca polysac-
charides to improve the defensive nature of liver against free
radicals (Qi et al., 2006).
Lipid peroxidation, measured as thiobarbituric acid reac-
tive species (TBARS), is a free-radical mediated propagation
of oxidative insult to polyunsaturated fatty acids involving
several types of free radicals (Korkina and Afanas’ev,
1997). The hypercholesterolemic rats of the present study
exhibited high signiﬁcant elevation of hepatic TBARS con-
centration as compared to normal control group (Table 5).
An increase of TBARS levels, in animals fed with a high
cholesterol diet has been previously reported (Shukla et al.,
2004; Visavadiya and Narasimhacharya, 2007). There was
a positive correlation between plasma total cholesterol and
triacylglycerol concentrations and free radicals generation
(Chen and Li, 2007). An abnormal rise in lipid peroxidation
was reduced with atorvastatine and the polysaccharide
administration, due to their antioxidant activity, emphasised
through in vitro experiments (Qi et al., 2006). This is in line
with the previous observation where algal polysaccharide
supplementation could circumvent the in vitro oxidation of
linoleic acid (Tannin et al., 2005). Sulfated polysaccharides
supplementation signiﬁcantly prevented the oxidative dam-
age to macromolecules by minimizing the levels of lipid per-
oxidation (Josephine et al., 2008).
Improvement of lipid proﬁle and antioxidant of hypercholesterolemic albino rats 3395. Conclusions
In conclusion, the supplementation of sulfated polysaccharide
extract ofU. lactuca to hypercholesterolemic rats is effective in
decreasing the oxidative stress and hypercholesterolemia devel-
opment, by increasing the activities of antioxidant enzymes
(CAT, GSH-Px and SOD), non-enzymes (GSH & T. thiol)
and limiting lipid peroxidation process. However, further clin-
ical studies are necessary to assess the beneﬁts and safety of
sulfated polysaccharide extracts before using for human beings
and approval by Food and Drug Administration (FDA) to be
used as drugs.References
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